Short-chain fatty acids: key antiviral mediators of gut microbiota

QR Code

Short-chain fatty acids: key antiviral mediators of gut microbiota

The effects of gut microbiota on antiviral immunity have been well-documented in recent years, whereas a mechanistic understanding of microbiota-derived metabolite-related signaling pathways is still lacking. Short-chain fatty acids (SCFAs), key metabolites produced by gut bacterial microbiota via d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhiqiang Xu, Tao Wang, Yanjin Wang, Yongfeng Li, Yuan Sun, Hua-Ji Qiu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	antiviral immunity G-protein-coupled receptor gut microbiota histone acetyltransferase histone deacetylase short-chain fatty acid
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1614879/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends
by: Huong Anh Mai, et al.
Published: (2025-06-01)

A missense mutation in the Sin3 subunit of Rpd3 histone deacetylase complex bypasses the requirement for FNG1 in wheat scab fungus
by: Huaijian Xu, et al.
Published: (2025-08-01)

Histone Acetyltransferase MOF-Mediated AURKB K215 Acetylation Drives Breast Cancer Cell Proliferation via c-MYC Stabilization
by: Yujuan Miao, et al.
Published: (2025-07-01)

Enzyme-independent functions of HDAC3 in the adult heart
by: Sichong Qian, et al.
Published: (2025-07-01)

Epigenetic modifications of gut microbiota and their potential role in atherosclerosis
by: Shuang Guo, et al.
Published: (2025-07-01)

Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents
by: Jason H. Gill, et al.
Published: (2025-12-01)

Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis‐Frontotemporal Spectrum Disorder
by: Greet Vanderlinden, et al.
Published: (2025-07-01)

INDUCTION OF ACETYLATION PROCESSES IN ANIMALS WITH SEROTONERGIC NEURON DYSFUNCTION REVERSES THEIR CAPABILITY OF LONG-TERM MEMORY FORMATION
by: O. V. Vorobiova, et al.
Published: (2015-01-01)

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 2. GUT MICROBIOTA AND OBESITY
by: D. A. Kashtanova, et al.
Published: (2015-10-01)

Inhibitory Effect of Novel Dihydroxamate Derivatives for Histone Deacetylase 1
by: Jhawn G. Saul, et al.
Published: (2025-06-01)

Histone H3 Lysine 9 Acetylation Plays a Role in Adipogenesis of Periodontal Ligament-Derived Stem Cells
by: Julio A. Montero-Del-Toro, et al.
Published: (2025-05-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Role of Histone Deacetylases in Drug-Resistant Melanoma: Mechanisms and Therapeutic Implications
by: Bhuvanesh Sukhlal Kalal
Published: (2025-04-01)

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy
by: Rui Han, et al.
Published: (2025-05-01)

VPA Enhances Pulp Regeneration by Regulating LPS-Induced Human Dental Pulp Stem Cells Odontogenic Differentiation
by: Zhihua Wang, et al.
Published: (2025-08-01)

GCN5 Is a Master Regulator of Gene Expression in the Malaria Parasite <i>Plasmodium falciparum</i>
by: Amuza Byaruhanga Lucky, et al.
Published: (2025-06-01)

Effectiveness of personalized granola tailored to the gut microbiota for improving gut environment and mood states
by: Hiroyuki Sasaki, et al.
Published: (2025-07-01)

Melatonin Mitigates Sarcopenic Obesity via Microbiota and Short‐Chain Fatty Acids: Evidence From Epidemiologic and In Vivo Studies
by: Xiaoxing Mo, et al.
Published: (2025-06-01)

Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis
by: Chuanjian Yuan, et al.
Published: (2025-07-01)

Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota
by: D. A. Kashtanova, et al.
Published: (2016-02-01)

EPIGENETIC REGULATION OF GENE EXPRESSION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: THERAPEUTIC PERSPECTIVES
by: R. B. Samsonov, et al.
Published: (2017-04-01)

Correlations of serum histone deacetylase 3 and thrombospondin-1 levels with cardiac function grades, ventricular remodeling, and prognosis in patients with chronic heart failure
by: Jiange Cheng, et al.
Published: (2025-06-01)

Ozone rectal insufflation inhibits the development of atherosclerosis in ApoE−/−mice, which is mediated by the regulation of gut microbiota and metabolites
by: Ruihua Li, et al.
Published: (2025-06-01)

Gut microbiota regulates serum metabolites in mice with nonalcoholic fatty liver disease via gut metabolites: mechanisms involving branched-chain amino acids and unsaturated fatty acids
by: Hao Qiu, et al.
Published: (2025-07-01)

Impact of the Gut Microbiota–Metabolite Axis on Intestinal Fatty Acid Absorption in Huainan Pigs
by: Jing Wang, et al.
Published: (2025-07-01)

Histones post-translational modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 3. Histon acetylation
by: O.E. Abaturov, et al.
Published: (2025-03-01)

The role of gut microbiota in insulin resistance: recent progress
by: Hongfang Ji, et al.
Published: (2025-07-01)

Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
by: Xiaoran Wang, et al.
Published: (2025-06-01)

Metabolic potential of gut microbiota in helminth infections as a way to achieve bronchial asthma control
by: T. S. Sokolova, et al.
Published: (2023-10-01)

Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development
by: L. E. Vasilyeva, et al.
Published: (2021-11-01)

Jiedutongluotiaogan Formula Improves Pancreatic Dysfunction in db/db Mice through Modulating the Gut Microbiota-Short Chain Fatty Acids-NLR Family, Pyrin Domain–Containing Protein 3 Inflammasome
by: Jin-Li Luo, et al.
Published: (2025-04-01)

Interplay between gut microbiota and acute kidney injury: a review of their mutual influence and causation
by: Niroj Mali, et al.
Published: (2025-12-01)

Multi-omics integration reveals chromatin-associated lncRNA prognostic model in lung adenocarcinoma: Bridging GWAS, transcriptome and clinical outcomes
by: Xiao Zhu, et al.
Published: (2025-08-01)

Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability
by: Rong Wang, et al.
Published: (2025-07-01)

Gut microbiota-derived SCFAs and MetS-related nephropathy
by: Xiaofang Tian, et al.
Published: (2025-07-01)

Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis
by: Yun Long, et al.
Published: (2025-06-01)

Lactobacillus helveticus mitigates diarrhea and inflammation induced by enterotoxigenic E. coli through rebalance of gut microbiota
by: Zhen Zhang, et al.
Published: (2025-01-01)

Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
by: Ilinca Savulescu-Fiedler, et al.
Published: (2025-06-01)

Epigenetic Modulation by Lactylation in Sepsis: Linking Metabolism to Immune Dysfunction
by: Chen Y, et al.
Published: (2025-06-01)

Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
by: Luyu Wang, et al.
Published: (2025-07-01)